Labcorp business update

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading life sciences company, today issued the following statement: labcorp continues to make progress executing our strategy and capitalizing on the power of our diagnostic and drug development businesses. we are successfully accelerating growth across our platform, while playing a critical role in the fight against covid-19 and helping our clients develop next-generation solutions for other key therapeutic areas such as oncology, liver
LH Ratings Summary
LH Quant Ranking